CVRest

Create your CV
Create your CV

Summary

自2016年起，我在西班牙巴塞罗那生活和学习，先后完成硕士和博士学位，目前从事博士后研究工作。同时，长期提供中文、西班牙语、英语及加泰罗尼亚语（巴塞罗那地区语言）多语种翻译与口译服务。

工作经验涵盖本地华人社群陪同口译，包括医疗就诊、教育事务、法律咨询等；此外，还专注于国际商务口译，服务内容包括展会陪同翻译、代参展、客户沟通、客户拓展与关系维护等。同时，也具备丰富的导游经验，曾为来访的个人游客与商务团体提供中西双语讲解服务，熟悉西班牙历史、文化、地理及主要旅游景点，能够结合语言能力与本地知识，提升游客体验。

多年来深度参与中西语言服务与跨文化交流工作，积累了扎实的沟通与组织能力，熟悉西班牙商业礼仪与社交方式，能够提供高质量、具文化敏感性的翻译与导览服务，助力客户实现高效、顺畅的跨文化沟通与合作。

Projects

Characterization and therapeutic impact of the ecology of HER2-positive breast cancer. INSTITUTO DE SALUD CARLOS III

Predoctoral

September 2021 - September 2022

Prediction of residual disease following neoadjuvant therapy in HER2-positive breast cancer and identification of strategies to overcome resistance. INSTITUTO DE SALUD CARLOS III

Predoctoral

September 2022 - December 2024

Identification and prediction biomarkers using TMA analysis in breast cancer patients

Main participant

October 2017 - December 2018

Evaluate senescence and the senolytic effect of digoxin in mouse and human tumor explants (ex-vivo) in the framework of the Cancer Innova Program. KAERTOR

Main participant

June 2022 - October 2023

Thesis: Effects of palbociclib on the cellular and immune response to trastuzumab and pertuzumab in HER2-positive breast cancer

Main participant

January 2019 - October 2023

Evaluate senescence and the senolytic effect of Bcl-2 inhibitors in mouse and human tumor explants (ex-vivo)

Main participant

October 2022 - June 2024

Education

University of Medical Sciences of Havana

Clinical medicine

2010 - 2016

University of Barcelona

Oncology - Master in Clinical Research

2016 - 2017

Autonomous University of Barcelona

Doctor of Medicine

2019 - 2023

Achievements

Cuba Unilateral Scholarship for Undergrad's Degree Students（2009 to 2016）

China Scholarship Council for Master's Degree Students (2016 to 2017)

China Scholarship Council for PhD's Degree Students (2017 to 2021)

Publications

Title: mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive breast cancer.

Authors: David Casadevall# , Anna Hernandez-Prat# , Sara Garcia-Alonso, Oriol Arpi Llucia, Silvia Menendez, Mengjuan Qin et al., Molecular Cancer Research 2022

Title: Enhancing Immunotherapy Efficacy through PD-L1 upregulation: The promise of combining Anti-PD-L1 and mTOR inhibitors

Authors: Anna Hernández-Prat, Alejo Rodriguez-Vida, Laura Cardona, Mengjuan Qin et al., Molecular Oncology 2024

Title: Enhancing CDK4/6 inhibition and anti-HER2 therapy by targeting senescence in HER2+ breast cancer

Mengjuan Qin et al., Submitted to Cancer Discovery (under review, major revision) 2024

Participation in international conferences

Title: Dual HER2 blockade and CDK4/6 inhibition modulate tumor intrinsic immune response markers in HER2-positive breast cancer.

Authors: Mengjuan Qin et al., Congress: IV Young Researchers Meeting of CIBERONC/CIBER-BBN. 13-14 December 2021, Barcelona, Spain.

Title: Mechanisms of acquired resistance to trastuzumab, pertuzumab, and palbociclib in HER2-positive breast cancer.

Authors: Mengjuan Qin et al., Congress: European Association for Cancer Research Congress (EACR)—Innovative Cancer Science: Translating Biology to Medicine. 20-23 June 2022, Seville, Spain. 2021 2-Year Impact Factor: 7.449

Title: Resistance to interferon-gamma (IFN-gamma) in HER2-positive breast cancer cells.

Authors: Luis Soria-Jiménez, Mengjuan Qin et al., Congress: European Association for Cancer Research Congress (EACR)—Innovative Cancer Science: Translating Biology to Medicine. 20-23 June 2022, Seville, Spain. 2021

Title: The role of mTOR inhibitors in the tumor immune microenvironment and PD-L1 expression in bladder cancer.

Authors: Anna Hernández-Prat, Alejo Rodriguez-Vida, Mengjuan Qin et al., Congress: European Association for Cancer Research Congress (EACR)—Innovative Cancer Science: Translating Biology to Medicine. 20-23 June 2022, Seville, Spain. 2021

Title: The role of mTOR inhibitor TAK-228 in the tumor immune microenvironment and PD-L1 expression in bladder cancer’s preclinical models.

Authors: Anna Hernández-Prat, Raúl del Rey, Fabricio Quimis, Mengjuan Qin et al. Congress: ASEICA 40th anniversary. 14-16 November 2023, A coruña, Spain.

Skills

  • Molecular biology

    Cell culture, molecular analysis including protein and gene expression

  • Statistical analysis

    programs R, SPSS, machine learning and python

  • Manipulation in vivo analysis

    Certificate of use of experimental animals level A+B+C+D

Languages

Language

Spanish: 

Oral fluency level C2 (9.2/10 excellent) in Pompeu Fabra University Barcelona 2024

Language

English: 

Certificate of procifiency C1.2 in Pompeu Fabra University Barcelona 2019

Language

Chinese: 

Mother Tongue

CV SummaryContact